Orthofix Medical Inc (OFIX) Stock Analysis
Verdict: AVOID
Severe technical breakdown and rising debt overshadow high gross margins and insider buying — the model expects a 52-week low breach.
Investment score: 38/100
Analysis as of
Is Orthofix Medical Inc stock worth reviewing? The TradeMates thesis
OFIX is a medical device firm with high-quality products but poor capital efficiency. Technical momentum is currently too negative to ignore, regardless of perceived 'cheapness'.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 30/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 40/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
Orthofix Medical Inc opportunities and risks
What speaks for OFIX
- Elite Gross Margins (70.75%)
What speaks against OFIX
- Technical Capitulation and Low-Volume Drift
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| OFIX | n/a | 0.5x | 5.1x | 69.0% | -7.3% | -1.0% |
| ANGO | n/a | 1.5x | n/a | 53.5% | -10.0% | 0.3% |
| CLPT | n/a | 9.2x | n/a | 61.8% | -71.6% | -7.1% |
| VREX | n/a | 0.5x | 737.1x | 33.6% | -9.6% | -7.0% |
| DCTH | 693.5x | 4.1x | 1026.2x | 86.0% | 0.6% | 5.1% |
| Peer median | n/a | 2.8x | 360.1x | 57.6% | -9.8% | -3.3% |
Frequently asked questions about Orthofix Medical Inc (OFIX)
Is OFIX stock a good investment?
The TradeMates model rates Orthofix Medical Inc as AVOID with an investment score of 38/100. OFIX is a medical device firm with high-quality products but poor capital efficiency. Technical momentum is currently too negative to ignore, regardless of perceived 'cheapness'. This is algorithmic model output, not personal investment advice.
Is OFIX stock a buy?
The TradeMates model verdict for OFIX is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.